SB 573

  • Rhode Island Senate Bill
  • 2023 Regular Session
  • Introduced in Senate Mar 07, 2023
  • Senate
  • House
  • Governor

AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT (Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name on list.)

Votes


No votes to display

Actions


May 09, 2023

Rhode Island General Assembly

05/09/2023 Committee recommended measure be held for further study

May 05, 2023

Rhode Island General Assembly

05/05/2023 Scheduled for hearing and/or consideration (05/09/2023)

Apr 04, 2023

Rhode Island General Assembly

04/04/2023 Committee recommended measure be held for further study

Mar 31, 2023

Rhode Island General Assembly

03/31/2023 Scheduled for hearing and/or consideration (04/04/2023)

Mar 07, 2023

Senate

03/07/2023 Introduced, referred to Senate Health and Human Services

Bill Text

Bill Text Versions Format
573 PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Rhode Island General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.